Accession Number: | 0000899866-21-000052 |
Date: | 2021-07-14 |
Issuer: | ALEXION PHARMACEUTICALS, INC. (ALXN) |
Original Submission Date: |
CARINO TANISHA
C/O ALEXION PHARMACEUTICALS, INC.
121 SEAPORT BOULEVARD
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK, PAR VALUE $.0001 PER SHARE | 2021-07-14 | A | 25,813 | a | $0.00 | 59,226 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | on july 14, 2021 the leadership and compensation committee certified that certain performance metrics under previously granted performance stock units were satisfied. these performance stock units were previously granted in february 2020 under the 2017 stock incentive plan. |